Hyperactivation of TORC1 Drives Resistance to the Pan-HER Tyrosine Kinase Inhibitor Neratinib in HER2-Mutant Cancers
Titel:
Hyperactivation of TORC1 Drives Resistance to the Pan-HER Tyrosine Kinase Inhibitor Neratinib in HER2-Mutant Cancers
Auteur:
Sudhan, Dhivya R. Guerrero-Zotano, Angel Won, Helen Ericsson, Paula González Servetto, Alberto Huerta-Rosario, Mariela Ye, Dan Lee, Kyung-min Formisano, Luigi Guo, Yan Liu, Qi Kinch, Lisa N. Brewer, Monica Red Dugger, Teresa Koch, James Wick, Michael J. Cutler Jr., Richard E. Lalani, Alshad S. Bryce, Richard Auerbach, Alan Hanker, Ariella B. Arteaga, Carlos L.